These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is British Biotech's Marimastat a major cancer drug? Davidson S Nat Biotechnol; 1996 Jul; 14(7):819-20. PubMed ID: 9630998 [No Abstract] [Full Text] [Related]
3. Biotech's wellspring: the health of private biotech in 2013. Huggett B Nat Biotechnol; 2014 May; 32(5):428-35. PubMed ID: 24811512 [No Abstract] [Full Text] [Related]
4. A blueprint for biotech's blues. Nat Biotechnol; 2009 Aug; 27(8):675. PubMed ID: 19668152 [TBL] [Abstract][Full Text] [Related]
10. Indian biotech's bumpy road. Basu P Nature; 2007 Nov; 450(7169):580-1. PubMed ID: 18087777 [No Abstract] [Full Text] [Related]
11. Biotech's wellspring: a survey of the health of the private sector. Huggett B Nat Biotechnol; 2012 May; 30(5):395-400. PubMed ID: 22565961 [No Abstract] [Full Text] [Related]
16. [Progress in diagnosis and treatment of lung cancer]. Fukuoka M Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():15-22. PubMed ID: 11989256 [No Abstract] [Full Text] [Related]
17. Biotech's wellspring-a survey of the health of the private sector in 2016. Lawrence S Nat Biotechnol; 2017 May; 35(5):413-420. PubMed ID: 28486451 [No Abstract] [Full Text] [Related]
18. Marimastat therapy as adjuvant to selective embolization in skeletal metastases of differentiated thyroid carcinoma. Smit JW; van Tol KM; Hew JM; Vielvoye GJ; Romijn JA; Links TP Clin Endocrinol (Oxf); 2001 Sep; 55(3):421-2. PubMed ID: 11589688 [No Abstract] [Full Text] [Related]